1 Allergy Unit, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.
2 Anatomical Pathology Unit, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.
Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419827771. doi: 10.1177/2058738419827771.
The eosinophilic oesophagitis (EoE) is a chronic immune/antigen disorder of the oesophagus clinically characterized by dysphagia and pathologically by mucosa eosinophilic infiltration. Th2-type allergic reactions are considered having important roles in the aetiopathogenesis of EoE. Avoidance of food allergens, administration of steroidal anti-inflammatory medications and dilation of the oesophagus are the most important treatments. 'Systemic nickel allergy syndrome' (SNAS) interests about 20% of patients with nickel contact allergy which could present systemic cutaneous manifestations (urticaria, oedema, etc.) and also respiratory and digestive symptoms (meteorism, abdominal pain, diarrhoea, etc.). In the literature, it is demonstrated that nickel oral immunotherapy is effective in reducing symptoms of SNAS and in modulating inflammatory parameters. We describe the case of a 48-year-old woman suffering from EoE not responsive to the topical steroid administration and diagnosis of SNAS. The patient started nickel oral desensitization according to the literature protocol continuing nickel-free diet. After 1 year from the beginning of the treatment, during the maintenance dose (500 ng three times a week), she decreased gradually the dosage of immunotherapy and reintroduced all the culprit foods. After the immunotherapy interruption, during the free diet, she repeated the oesophagogastroscopy with a complete macroscopic and histological resolution. We showed the first case of an EoE in a patient affected by SNAS responsive to the nickel-free diet and the oral immunotherapy.
嗜酸性食管炎(EoE)是一种慢性免疫/抗原性食管疾病,临床上表现为吞咽困难,病理学上表现为黏膜嗜酸性粒细胞浸润。Th2 型过敏反应被认为在 EoE 的发病机制中起重要作用。避免食物过敏原、使用类固醇抗炎药物和食管扩张是最重要的治疗方法。“全身性镍过敏综合征”(SNAS)约占镍接触过敏患者的 20%,可出现全身性皮肤表现(荨麻疹、水肿等)和呼吸道和消化道症状(气胀、腹痛、腹泻等)。文献表明,镍口服免疫疗法可有效减轻 SNAS 的症状,并调节炎症参数。我们描述了一位 48 岁女性的病例,她患有对局部类固醇治疗无反应的 EoE 和 SNAS 诊断。该患者根据文献方案开始进行镍口服脱敏治疗,同时继续进行无镍饮食。治疗 1 年后,在维持剂量(每周 500ng,分 3 次服用)时,她逐渐减少免疫治疗剂量并重新引入所有致病食物。免疫治疗中断后,在无饮食限制期间,她再次进行了食管胃十二指肠镜检查,结果显示宏观和组织学完全缓解。我们报告了首例 EoE 患者在 SNAS 中对无镍饮食和口服免疫治疗有反应的病例。